LO9A Stock Forecast - VBI Vaccines Inc

	VBI Vaccines Inc F:LO9A	US
	Genenta Science SPA NASDAQ:GNTA	IT
V	Vienna Insurance Group Wiener Versicherung Gruppe AG SWB:WSV2	AT
	Peak Minerals Ltd ASX:PUA	AU
	AudioEye Inc NASDAQ:AEYE	US
F	Fajarbaru Builder Group Bhd KLSE:FAJAR	MY
	Baru Gold Corp XTSX:BARU	CA
	Dal'nevostochnoye Morskoye Parokhodstvo PAO MOEX:FESH	RU
	Roadman Investments Corp XTSX:LITT	CA
	Peraso Inc NASDAQ:PRSO	US

Wall St Price Targets

There are no price targets for LO9A.

LO9A Lowest Forecast

LO9A Average Forecast

LO9A Highest Forecast

Ardelyx Inc

329% Upside

News Corp

14% Upside

V

Verkkokauppa.com Oyj

9% Upside

Ardelyx Inc

329% Upside

News Corp

14% Upside

V

Verkkokauppa.com Oyj

9% Upside

Revenue
Forecast

48% / Year

Past Growth

90% / Year

Estimated Growth

Estimates Accuracy

-22%

Average Miss

48% / Year

Past Growth

90% / Year

Estimated Growth

Estimates Accuracy

-22%

Average Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 48%. The projected CAGR for the next 3 years is 90%.

What are analyst estimates?

Gross Profit
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Continue LO9A Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

NASDAQ • USD

VBIV

NASDAQ • USD

VBIV1

OTC • USD

VBIVQ

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

LO9A does not have any price targets made by Wall Street professionals.

Over the last 7 years, the compound annual growth rate for Revenue has been 48%. The projected CAGR for the next 3 years is 90%.

Back to Top

VBI Vaccines Inc
F:LO9A

Wall St Price Targets

LO9A Price Targets Summary
VBI Vaccines Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue LO9A Research

What is LO9A's stock price target?

Not Available

What is the Revenue forecast for VBI Vaccines Inc?

Projected CAGR
90%

Company

Help

Tools

Stocks

VBI Vaccines Inc F:LO9A

Wall St Price Targets

LO9A Price Targets Summary VBI Vaccines Inc

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue LO9A Research

What is LO9A's stock price target? Not Available

What is the Revenue forecast for VBI Vaccines Inc? Projected CAGR 90%

Company

Help

Tools

Stocks

VBI Vaccines Inc
F:LO9A

LO9A Price Targets Summary
VBI Vaccines Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is LO9A's stock price target?

Not Available

What is the Revenue forecast for VBI Vaccines Inc?

Projected CAGR
90%